Wendy Ying1, Di Zhao2, Pamela Ouyang1, Vinita Subramanya1, Dhananjay Vaidya2,3, Chiadi E Ndumele1,2, Kavita Sharma1, Sanjiv J Shah4, Susan R Heckbert5, Joao A Lima1, Christopher R deFilippi6, Matthew J Budoff7, Wendy S Post1,2, Erin D Michos1,2. 1. Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland. 2. Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland. 3. Division of General Internal Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland. 4. Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois. 5. Cardiovascular Health Research Unit and Department of Epidemiology, University of Washington, Seattle, Washington. 6. Inova Heart and Vascular Institute, Falls Church, Virginia. 7. Harbor-UCLA Medical Center, David Geffen School of Medicine, Los Angeles, California.
Abstract
Context: Sex hormones may influence sex differences in cardiovascular disease (CVD). N-terminal pro-B-type natriuretic peptide (NT-proBNP), a predictor of CVD, is higher in women than men, which may relate to sex hormones. Objective: To evaluate whether total testosterone (T), bioavailable T, free T, estradiol, dehydroepiandrosterone (DHEA), and SHBG are associated with NT-proBNP. Design: Cohort study. Participants: Cross-sectional sample included 2371 postmenopausal women and 2688 men free of CVD, of which 2041 women and 2348 men were included longitudinally. Main Outcome Measures: NT-proBNP at baseline (2000 to 2002) and one or more repeat NT-proBNPs (through 2012). Analyses adjusted for CVD risk factors. Results: Women had higher NT-proBNP than men (median 79.9 vs 38.5 pg/mL). Cross-sectionally, higher bioavailable T, free T, DHEA, and lower SHBG levels were independently associated with lower NT-proBNP among both women and men (all P < 0.05). Higher total T in women and estradiol in men were also associated with lower NT-proBNP (both P < 0.05). Longitudinally, in women, higher total T, bioavailable T, free T, DHEA, and lower estradiol and SHBG were associated with greater 10-year increase in NT-proBNP (all P < 0.05). In men, higher free T and estradiol were associated with greater NT-proBNP increase (both P < 0.05). Conclusions: A more androgenic sex hormone pattern was inversely associated with NT-proBNP cross-sectionally and may contribute to sex differences in NT-proBNP. Longitudinally, a more androgenic sex hormone pattern was associated with greater increase in NT-proBNP in women, which may reflect a mechanism for CVD risk after menopause.
Context: Sex hormones may influence sex differences in cardiovascular disease (CVD). N-terminal pro-B-type natriuretic peptide (NT-proBNP), a predictor of CVD, is higher in women than men, which may relate to sex hormones. Objective: To evaluate whether total testosterone (T), bioavailable T, free T, estradiol, dehydroepiandrosterone (DHEA), and SHBG are associated with NT-proBNP. Design: Cohort study. Participants: Cross-sectional sample included 2371 postmenopausal women and 2688 men free of CVD, of which 2041 women and 2348 men were included longitudinally. Main Outcome Measures: NT-proBNP at baseline (2000 to 2002) and one or more repeat NT-proBNPs (through 2012). Analyses adjusted for CVD risk factors. Results:Women had higher NT-proBNP than men (median 79.9 vs 38.5 pg/mL). Cross-sectionally, higher bioavailable T, free T, DHEA, and lower SHBG levels were independently associated with lower NT-proBNP among both women and men (all P < 0.05). Higher total T in women and estradiol in men were also associated with lower NT-proBNP (both P < 0.05). Longitudinally, in women, higher total T, bioavailable T, free T, DHEA, and lower estradiol and SHBG were associated with greater 10-year increase in NT-proBNP (all P < 0.05). In men, higher free T and estradiol were associated with greater NT-proBNP increase (both P < 0.05). Conclusions: A more androgenic sex hormone pattern was inversely associated with NT-proBNP cross-sectionally and may contribute to sex differences in NT-proBNP. Longitudinally, a more androgenic sex hormone pattern was associated with greater increase in NT-proBNP in women, which may reflect a mechanism for CVD risk after menopause.
Authors: Jens Peter Goetze; Rasmus Mogelvang; Lars Maage; Henrik Scharling; Peter Schnohr; Peter Sogaard; Jens F Rehfeld; Jan Skov Jensen Journal: Eur Heart J Date: 2006-11-21 Impact factor: 29.983
Authors: Jeanney Lew; Monika Sanghavi; Colby R Ayers; Darren K McGuire; Torbjørn Omland; Dorothee Atzler; Maria O Gore; Ian Neeland; Jarett D Berry; Amit Khera; Anand Rohatgi; James A de Lemos Journal: Circulation Date: 2017-02-07 Impact factor: 29.690
Authors: Eui-Young Choi; Hossein Bahrami; Colin O Wu; Philip Greenland; Mary Cushman; Lori B Daniels; Andre L C Almeida; Kihei Yoneyama; Anders Opdahl; Aditya Jain; Michael H Criqui; David Siscovick; Christine Darwin; Alan Maisel; David A Bluemke; Joao A C Lima Journal: Circ Heart Fail Date: 2012-10-02 Impact factor: 8.790
Authors: Kathryn M Rexrode; JoAnn E Manson; I-Min Lee; Paul M Ridker; Patrick M Sluss; Nancy R Cook; Julie E Buring Journal: Circulation Date: 2003-09-15 Impact factor: 29.690
Authors: Lena Mathews; Vinita Subramanya; Di Zhao; Pamela Ouyang; Dhananjay Vaidya; Eliseo Guallar; Joseph Yeboah; David Herrington; Allison G Hays; Matthew J Budoff; Erin D Michos Journal: J Womens Health (Larchmt) Date: 2019-06-06 Impact factor: 2.681
Authors: Nirav Patel; Orlando M Gutiérrez; Garima Arora; George Howard; Virginia J Howard; Suzanne E Judd; Sumanth D Prabhu; Emily B Levitan; Mary Cushman; Pankaj Arora Journal: Int J Cardiol Date: 2019-02-21 Impact factor: 4.164
Authors: Sunyoung Jang; Oluseye Ogunmoroti; Chiadi E Ndumele; Di Zhao; Vishal N Rao; Oluwaseun E Fashanu; Martin Tibuakuu; James D Otvos; Eve-Marie Benson; Pamela Ouyang; Erin D Michos Journal: Circ Heart Fail Date: 2020-07-28 Impact factor: 8.790
Authors: Mohammad R Ostovaneh; Kasra Moazzami; Kihei Yoneyama; Bharath A Venkatesh; Susan R Heckbert; Colin O Wu; Steven Shea; Wendy S Post; Annette L Fitzpatrick; Gregory L Burke; Hossein Bahrami; Otto A Sanchez; Lori B Daniels; Erin D Michos; David A Bluemke; João A C Lima Journal: Hypertension Date: 2019-12-23 Impact factor: 10.190
Authors: Richard A Ferraro; Oluseye Ogunmoroti; Di Zhao; Chiadi E Ndumele; Vishal Rao; Ambarish Pandey; Nicholas B Larson; Suzette J Bielinski; Erin D Michos Journal: J Card Fail Date: 2021-05-26 Impact factor: 6.592
Authors: Vinita Subramanya; Di Zhao; Pamela Ouyang; Wendy Ying; Dhananjay Vaidya; Chiadi E Ndumele; Joao A Lima; Eliseo Guallar; Ron C Hoogeveen; Sanjiv J Shah; Susan R Heckbert; David A Kass; Wendy S Post; Erin D Michos Journal: Biomarkers Date: 2021-03-09 Impact factor: 2.663
Authors: Xiaoming Jia; Caroline Sun; Olive Tang; Ivan Gorlov; Vijay Nambi; Salim S Virani; Dennis T Villareal; George E Taffet; Bing Yu; Jan Bressler; Eric Boerwinkle; B Gwen Windham; James A de Lemos; Kunihiro Matsushita; Elizabeth Selvin; Erin D Michos; Ron C Hoogeveen; Christie M Ballantyne Journal: J Clin Endocrinol Metab Date: 2020-12-01 Impact factor: 5.958
Authors: Marie-Pierre St-Onge; Brooke Aggarwal; Matthew A Allison; Jeffrey S Berger; Sheila F Castañeda; Janet Catov; Judith S Hochman; Carl A Hubel; Sanja Jelic; David A Kass; Nour Makarem; Erin D Michos; Lori Mosca; Pamela Ouyang; Chorong Park; Wendy S Post; Robert W Powers; Harmony R Reynolds; Dorothy D Sears; Sanjiv J Shah; Kavita Sharma; Tanya Spruill; Gregory A Talavera; Dhananjay Vaidya Journal: J Am Heart Assoc Date: 2021-02-23 Impact factor: 5.501